OrbiMed

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Sep 18, 2026

OrbiMed invests globally across healthcare, from early private companies to large public businesses, covering biopharmaceuticals, medical devices, diagnostics, digital health and healthcare services.

The team combines scientific, medical and investment expertise. Its capital and resources are tailored to the company, allowing the platform to support different development needs across a drug programme, a medical device or a care-delivery business.

Its private and public investment activity spans the healthcare company lifecycle. Founders can engage with a specialist healthcare investor while their technology is still developing, with expertise that also reaches clinical and commercial-scale businesses.

Sources
Rounds participated in
0
Confirmed lead rounds
—
All roles disclosed
New companies
0
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

No activity in this selection.

By primary sector

No activity in this selection.

By country

No activity in this selection.

Rounds

0 in this selection

No rounds match this selection.